Across TCGA pan-cancer cohorts, TRGJP RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of TRGJP’s most consistent transcriptional readouts.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where TRGJP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TRGJP is over-expressed in tumor.

PRAD are the cancer types where TRGJP tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in TRGJP RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PRAD	All	All	+0.425	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: TRGJP RNA expression & survival · all TRGJP data types